financetom
Business
financetom
/
Business
/
Abercrombie & Fitch lifts fourth-quarter sales target on strong holiday demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Abercrombie & Fitch lifts fourth-quarter sales target on strong holiday demand
Jan 13, 2025 4:28 AM

(Reuters) - Abercrombie & Fitch ( ANF ) on Monday raised its annual net sales growth target for the current quarter helped by strong demand for its apparel collections during the holiday shopping season.

The company now expects fourth-quarter net sales to grow between 7% and 8%, compared with the prior target of 5% to 7% growth.

(Reporting by Juveria Tabassum in Bengaluru; Editing by Mrigank Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Consumer products company Grove's Q2 revenue falls on reduced ads, net loss narrows on cost cuts
Consumer products company Grove's Q2 revenue falls on reduced ads, net loss narrows on cost cuts
Aug 7, 2025
Overview * Grove Q2 revenue falls 15.5% yr/yr to $44.0 mln, sequentially up 1.1% * Net loss improves to $3.6 mln from $10.1 mln last year * Adjusted EBITDA negative $0.9 mln, down from $1.1 mln last year Outlook * Grove expects Q3 revenue to improve, Q4 revenue to grow year-over-year * Full-year 2025 revenue expected to decline mid-single to...
Gilead Sciences Q2 Adjusted Earnings Unchanged, Revenue Rises; Dividend Maintained
Gilead Sciences Q2 Adjusted Earnings Unchanged, Revenue Rises; Dividend Maintained
Aug 7, 2025
04:34 PM EDT, 08/07/2025 (MT Newswires) -- Gilead Sciences ( GILD ) reported fiscal Q2 adjusted earnings late Thursday of $2.01 per diluted share, unchanged from a year earlier. Analysts polled by FactSet expected $1.96. Revenue for the quarter ended June 30 was $7.08 billion, up from $6.95 billion a year earlier. Analysts surveyed by FactSet expected $6.98 billion. The...
Digital health firm OptimizeRx beats Q2 revenue view, raises FY guidance
Digital health firm OptimizeRx beats Q2 revenue view, raises FY guidance
Aug 7, 2025
Overview * OptimizeRx ( OPRX ) Q2 revenue grows 55% yr/yr, beating analyst expectations, per LSEG data * Adjusted EBITDA for Q2 beats consensus, reflecting strong operational performance * Co raises full-year 2025 guidance for revenue and adjusted EBITDA Outlook * Company raises 2025 revenue guidance to $104 mln-$108 mln * OptimizeRx ( OPRX ) expects 2025 adjusted EBITDA of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved